China Pharma Holdings CPHI
NYSE CPHI
$1.04 -0.04 (-3.70%)
At close: Aug 20, 2026 · 3:08 PM UTC

China Pharma Holdings (CPHI) Free Cash Flow Growth (1y) (2011 - 2026)

China Pharma Holdings (CPHI) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Haleon 43.86 Bn 42.90 Bn - -
2 Teva Pharmaceutical Industries 43.19 Bn 39.54 Bn 2.15 Bn 134.35%
3 Zoetis 31.46 Bn 29.79 Bn 1.05 Bn 17.21%
4 Takeda Pharmaceutical 28.57 Bn 22.77 Bn 5.10 Bn -37.45%
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn 58.76%
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 97.24%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 43.69%
8 Elanco Animal Health 11.71 Bn 11.18 Bn 798.00 Mn 35.56%
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 China Pharma Holdings 42.14 Mn 41.84 Mn 83,566.00 -111.96%

Historic Data

Download Data
DateValue
Mar 31, 2026 58.11%
Dec 31, 2025 -45.73%
Sep 30, 2025 -529.70%
Jun 30, 2025 522.13%
Mar 31, 2025 77.44%
Dec 31, 2024 1,139.96%
Sep 30, 2024 -104.01%
Jun 30, 2024 65.68%
Mar 31, 2024 58.57%
Dec 31, 2023 -104.39%
Sep 30, 2023 2,911.59%
Jun 30, 2023 58.37%
Mar 31, 2023 -60.33%
Dec 31, 2022 398.22%
Sep 30, 2022 96.14%
Jun 30, 2022 -175.31%
Mar 31, 2022 -218.09%
Dec 31, 2021 -136.16%
Sep 30, 2021 -79.16%
Jun 30, 2021 268.49%